388
Participants
Start Date
September 30, 2010
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2015
Mometasone Furoate monohydrate
Intranasal mometasone, 1 spray (age \< 12 yr) or 2 sprays (age \>= 12 yrs) each nostril once a day for 6 months
Placebo
Intranasal placebo spray
New York University School of Medicine, New York
New York Medical College, Valhalla
North Shore-Long Island Jewish Health System, New Hyde Park
Univeristy of Virginia, Charlottesville
Duke University Medical Center, Durham
Nemours Children's Clinic, Jacksonville
Univeristy of Miami School of Medicine, Miami
University of South Florida College of Medicine, Tampa
Davis Heart and Lung Research Institute, Columbus
Indiana University, Indianapolis
Northwestern Memorial Hospital, Chicago
Washington University School of Medicine, St Louis
University of Missouri, Kansas City School of Medicine, Kansas City
Louisiana State University Health Sciences Center, New Orleans
Baylor College of Medicine, Houston
National Jewish Health, Denver
University of Arizona, Tucson
University of California, San Diego, San Diego
Vermont Lung Center at the University of Vermont, Burlington
Lead Sponsor
National Institutes of Health (NIH)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH
JHSPH Center for Clinical Trials
OTHER